Leveraging Genetically Engineered Mouse Models of Small Cell Lung Cancer for Advanced Therapeutic St

Anna Farago, MD
We have developed a series of genetically engineered mouse models of SCLC, in which conditional deletion of the tumor suppressor genes p53 and Rb1 in pulmonary epithelial cells triggers initiation of tumors that mirror the histology

• Kategorie